ArticleFrontiers in oncology2021

Proteomics Analysis Identified ASNS as a Novel Biomarker for Predicting Recurrence of Skull Base Chordoma.

Yutao Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.